Neuroscience
A new study, published in Nature, shows a functional link between the gut microbiota and amyotrophic lateral sclerosis (ASL).
Scientists at KU Leuven summarized existing data on how SCFAs regulate the gut–brain axis, including the impact on the immune, endocrine and neural systems.
Specific gut bacteria break down levodopa, which is used to treat Parkinson’s. This could lead to the development of new levodopa therapies.
A study published in Cell provides further support to the idea that the microbes found in the gut of people with autism could have a role in their symptoms.
Modulating the gut microbiota may help to ease anxiety, according to a study published in General Psychiatry.
According to a new study published in The Journal of Experimental Medicine, antibiotic treatment reduces Alzheimer’s disease symptoms.
According to a recent study, the gut microbiota could determine remittance or pro-inflammatory conditions in multiple sclerosis.
Intestinal microbiota might be linked to neurodevelopment in early childhood, a new study published in JAMA Network Open finds.
Some gut bacteria might influence mood and prevent depression, according to a new study published in Nature Biotechnology.
According to Prof. Ted Dinan, who has been investigating the brain-intestinal axis for years, the gut microbiota plays a role in the genesis of depression.
